dacarbazine and Cancer of Ovary
dacarbazine has been researched along with Cancer of Ovary in 22 studies
Research
Studies (22)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (18.18) | 18.7374 |
1990's | 6 (27.27) | 18.2507 |
2000's | 9 (40.91) | 29.6817 |
2010's | 2 (9.09) | 24.3611 |
2020's | 1 (4.55) | 2.80 |
Authors
Authors | Studies |
---|---|
Coleman, RL; Demetri, GD; Herzog, TJ; Hu, P; Jones, RL; Knoblauch, R; McGowan, T; Monk, BJ; Patel, SR; Schuetze, SM; Shalaby, W; Triantos, S; Van Tine, BA; von Mehren, M | 1 |
Chang, M; Chen, TC; Geng, X; Liu, L; Song, X; Wang, W; Wang, X; Xie, L | 1 |
Huang, SC; Wu, PC; Yue, CT | 1 |
Jones, C; Plummer, ER | 1 |
Argenta, PA; Blair Harkness, C; Boente, MP; Carson, LF; Downs, LS; Judson, PL | 1 |
Barvaux, VA; Gillum, AM; Lorigan, P; Margison, GP; McElhinney, RS; McMurry, TB; Ranson, M | 1 |
Bookman, MA; Gallo, JM; Guo, P; Li, S; Ma, J; Orlansky, A; Pulfer, S; Vicini, P; Zhou, F | 1 |
Ball, HG; Chen, AH; Li, C; Quesenberry, CD; Zweizig, SL | 1 |
Duncan, T; Lindahl, T; Paik, J; Sedgwick, B | 1 |
Fishel, ML; He, Y; Kelley, MR; Smith, ML | 1 |
D'Incalci, M; Damia, G; Erba, E; Garattini, S; Morasca, L; Torti, L | 1 |
Barlow, JJ; DeEulis, TG; Lele, SB; Piver, MS | 1 |
Greenberg, S; Patsner, B | 1 |
Koĭnov, K; Tsvekova, V; Velikova, M | 1 |
Egorova, NI; Garin, AM; Gorozhanskaia, EG; Koroleva, EIu; Kushlinskiĭ, NE; Larionova, VB | 1 |
Chan, TH; Damian, Z; De Marte, J; Jean-Claude, BJ; Leyland-Jones, B; Mustafa, A; Vasilescu, DE; Yen, R | 1 |
Calvert, AH; Curtin, NJ; Delaney, CA; Durkacz, BW; Hostomsky, Z; Kyle, S; Newell, DR; Wang, LZ; White, AW | 1 |
Brown, R; Kaye, SB; Plumb, JA; Sludden, J; Strathdee, G | 1 |
Baker, TR; Caglar, H; Piedmonte, M; Piver, MS | 1 |
Shackney, S; Simon, SR; Uhl, M; Wang, SE | 1 |
Fanning, J; Piver, MS; Tsukada, Y; Zylstra, S | 1 |
Koĭnov, K; Marinov, L; Tsekova, V; Velikova, M | 1 |
Reviews
1 review(s) available for dacarbazine and Cancer of Ovary
Article | Year |
---|---|
Complete response after MAID treatment for advanced primary ovarian angiosarcoma: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Hemangiosarcoma; Humans; Ifosfamide; Mesna; Middle Aged; Ovarian Neoplasms | 2014 |
Trials
1 trial(s) available for dacarbazine and Cancer of Ovary
Article | Year |
---|---|
A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Dacarbazine; Drug Administration Schedule; Epithelial Cells; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Temozolomide | 2004 |
Other Studies
20 other study(ies) available for dacarbazine and Cancer of Ovary
Article | Year |
---|---|
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Cardiovascular Diseases; Child; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dacarbazine; Doxorubicin; Female; Heart; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Polyethylene Glycols; Product Surveillance, Postmarketing; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Stroke Volume; Trabectedin; Ventricular Function, Left; Young Adult | 2021 |
NEO212 induces mitochondrial apoptosis and impairs autophagy flux in ovarian cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagosomes; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Disease Models, Animal; DNA Damage; Female; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondria; Ovarian Neoplasms; Protein Transport; Xenograft Model Antitumor Assays | 2019 |
PARP inhibitors and cancer therapy - early results and potential applications.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Breast Neoplasms; Dacarbazine; Enzyme Inhibitors; Female; Humans; Melanoma; Mice; Ovarian Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Temozolomide | 2008 |
Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferase.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Cell Line, Tumor; Dacarbazine; DNA Repair; Dose-Response Relationship, Drug; Female; Humans; O(6)-Methylguanine-DNA Methyltransferase; Oligonucleotides; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; Temozolomide; Tetrazolium Salts; Thiazoles; Thionucleotides; Time Factors; Up-Regulation | 2004 |
Pharmacokinetic model-predicted anticancer drug concentrations in human tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Computer Simulation; Cyclohexanes; Dacarbazine; Female; Humans; Male; Models, Biological; O-(Chloroacetylcarbamoyl)fumagillol; Ovarian Neoplasms; Predictive Value of Tests; Rats; Rats, Inbred F344; Rats, Nude; Sesquiterpenes; Temozolomide; Topotecan; Transplantation, Heterologous; Vascular Endothelial Growth Factor A | 2004 |
Primary angiosarcoma of the ovary: a case report of Stage I disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Female; Hemangiosarcoma; Humans; Ifosfamide; Mesna; Neoplasm Staging; Ovarian Neoplasms | 2005 |
Sensitization of human carcinoma cells to alkylating agents by small interfering RNA suppression of 3-alkyladenine-DNA glycosylase.
Topics: Antineoplastic Agents, Alkylating; Carmustine; Cell Cycle; Dacarbazine; DNA Glycosylases; Female; Genetic Vectors; HeLa Cells; Humans; Methyl Methanesulfonate; Ovarian Neoplasms; RNA Interference; RNA, Small Interfering; Temozolomide; Ultraviolet Rays; Uterine Cervical Neoplasms | 2005 |
Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Base Sequence; Cell Line, Tumor; Dacarbazine; DNA Damage; DNA Glycosylases; DNA Repair; Dose-Response Relationship, Drug; Female; Humans; Hydroxylamines; Molecular Sequence Data; Ovarian Neoplasms; Temozolomide | 2007 |
Ovarian reticular cell sarcoma of the mouse (M5076) made resistant to cyclophosphamide.
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Cycle; Cell Line; Cyclophosphamide; Dacarbazine; Drug Resistance; Female; Lymphoma, Large B-Cell, Diffuse; Melphalan; Mice; Mice, Inbred C57BL; Ovarian Neoplasms | 1983 |
Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Prospective Studies; Sarcoma; Uterine Neoplasms; Vincristine | 1982 |
Mesna, doxorubicin, ifosfamide, and dacarbazine chemotherapy for ovarian mixed müllerian sarcoma: report of four cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Mesna; Middle Aged; Mixed Tumor, Mullerian; Ovarian Neoplasms; Sarcoma; Treatment Outcome | 1995 |
[Adjuvant chemotherapy in ovarian carcinoma. Preliminary results].
Topics: Adnexa Uteri; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bulgaria; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dacarbazine; Female; Fluorouracil; Humans; Hysterectomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Prospective Studies; Vincristine | 1993 |
[The role of glutathione and glutathione-S-transferase in neoplasm drug resistance].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dacarbazine; Drug Resistance, Neoplasm; Erythrocytes; Etoposide; Female; Glutathione; Glutathione Transferase; Humans; Male; Melanoma; Ovarian Neoplasms; Propionates; Skin Neoplasms; Testicular Neoplasms | 1998 |
Cytokinetics of a novel 1,2,3-triazene-containing heterocycle, 8-nitro-3-methyl-benzo-1,2,3,5-tetrazepin-4(3H)-one (NIME), in the human epithelial ovarian cancer cell line OVCAR-3.
Topics: Alkylation; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Azepines; Base Sequence; Binding Sites; Cell Cycle; Cell Division; Cell Survival; Dacarbazine; DNA Damage; DNA, Neoplasm; Female; Guanine; Humans; Ovarian Neoplasms; Plasmids; RNA, Neoplasm; Structure-Activity Relationship; Temozolomide; Tumor Cells, Cultured | 1999 |
Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Survival; Colonic Neoplasms; Dacarbazine; Drug Synergism; Enzyme Inhibitors; Female; Humans; Lung Neoplasms; Ovarian Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Temozolomide; Topotecan; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2000 |
Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Base Pair Mismatch; Carboplatin; Carrier Proteins; Cisplatin; Colonic Neoplasms; Dacarbazine; Decitabine; DNA Methylation; DNA Repair; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; MutL Protein Homolog 1; Neoplasm Proteins; Nuclear Proteins; Ovarian Neoplasms; Promoter Regions, Genetic; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2000 |
Prospective trial of cisplatin, adriamycin, and dacarbazine in metastatic mixed mesodermal sarcomas of the uterus and ovary.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Doxorubicin; Female; Humans; Leukocyte Count; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Platelet Count; Prospective Studies; Sarcoma; Survival Rate; Uterine Neoplasms | 1991 |
Complete response of carcinosarcoma of the ovary to therapy with doxorubicin, ifosfamide, and dacarbazine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Pelvis; Tomography, X-Ray Computed | 1991 |
Pathologic complete response of advanced ovarian mixed mesodermal tumor to cisplatin, adriamycin and dacarbazine: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Doxorubicin; Female; Humans; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms | 1989 |
[Comparative research on different treatment regimens in disseminated cancer of the ovaries].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Humans; Ovarian Neoplasms; Remission Induction | 1987 |